MimiVax LLC

MimiVax is a biotech startup with exclusive license to commercialize SurVaxM, a new vaccine to treat cancer.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Buffalo, NY, USA
  • Currency USD
  • Website mimivax.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free